Second Annual Boston Society Medical Symposium on Acute Myeloid Leukemia (AML)
October 4, 2019

Click Here to Download 2019 AML Program Guide

Broad Institute of MIT and Harvard 
415 Main Street 
Cambridge, MA 02142

Invited Speakers 

 

Daniel J. DeAngelo, MD, PhD, Chief of the Division of Leukemia, DFCI, Professor of Medicine, Harvard Medical School

Current Landscape for the Treatment of Patients with Acute Myloid  Leukeia

 

 

Terry Fry, MD, Professor of Pediatrics, Hematology and Immunology, Children's Hospital Colorado

Optimizing CAR T Cell for AML: What Can We Learn from Experience in ALL

             
 

Jacqueline S. Garcia, MD, Physician, DFCI, Instructor in Medicine, Harvard Medical School

Defining a Role for BH3 Mimetics in High Risk Myeloid Malignancies

     

Julie-Aurore Losman, MD, PhD, Assistant Professor, DFCI and Harvard Medical School

Epigenetic targets of R-2-hydroxyglutarate in IDH mutant tumors: Beyond TET2

 

             
   

Gwen Nichols, MD, Chief Medical Officer, The Leuklemia & Lymphoma Society

LLS Children's Initiative

     

Kelly Norsworthy MD, FDA, (DHHS/ FDA/CDER/ OMPT/CDER/ OND/OHOP/DHP)

Recent Drug Approvals in Acute Myeloid Leukemia

             
 

David Sallman, MD, Department of Malignant Hematology, Moffitt Cancer Center 

State of the Art Research and Treatment Updates: Advances in the Management of TP53 mutant Acute Myeloid Leukemia

     

Kimberly Stegmaier MD, Professor of Pediatrics, Harvard Medical School, Ted Williams Investigator, Dana-Farber Cancer Institute 

Application of Clinical and Functional Genomics to Pediatric AML

             
 

Mikael Rinne, MD, PhD, Senior Clinical Program Leader at Novartis Institutes for BioMedical Research

Emerging Immune-based Therapies in AML 

     

Jeffrey Venstrom, MD, SVP, Head of Clinical Development, Foundation Medicine

Enabling Genomic Actionability in the Clinic 

             

 AML 2019 Sessions 

Session I:  The Current Landscape - Updates

Session II:  State of the Art Research and Treatment Options - Updates

Session III:  On the Horizon

 

 

 Join our Linkedin Group:

Sessions

Session I:  The Current Landscape - Updates

Session II:  Session II - State of the Art Research and Treatment Updates

Session III:  On the Horizon

Registration

Click here to register for the AML 2019 conference online.

AML 2019 will take place

October 4, 2019

Broad Institute

Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy